teprotumumab
teprotumumab is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including TEPEZZA. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- teprotumumab
- Brand Names
- TEPEZZA
- Application Number
- BLA761143
- Sponsor
- Horizon Therapeutics USA, Inc.
- NDC Codes
- 2
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- TEPROTUMUMAB
Indications and Usage
1 INDICATIONS AND USAGE TEPEZZA is indicated for the treatment of Thyroid Eye Disease regardless of Thyroid Eye Disease activity or duration. TEPEZZA is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of Thyroid Eye Disease ( 1 )